These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9752340)

  • 1. [Update on genetic markers of cancer].
    Bénard J; Bressac-de Paillerets B
    Bull Cancer; 1998 Jan; 85(1):21-6. PubMed ID: 9752340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetic factors involved in cancer susceptibility].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1255-62. PubMed ID: 12146010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Familial (hereditary) cancer].
    Maekawa M
    Rinsho Byori; 2002 Nov; Suppl 123():121-30. PubMed ID: 12652799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
    Oliveira C; Sousa S; Pinheiro H; Karam R; Bordeira-Carriço R; Senz J; Kaurah P; Carvalho J; Pereira R; Gusmão L; Wen X; Cipriano MA; Yokota J; Carneiro F; Huntsman D; Seruca R
    Gastroenterology; 2009 Jun; 136(7):2137-48. PubMed ID: 19269290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary cancer predisposition syndromes.
    Garber JE; Offit K
    J Clin Oncol; 2005 Jan; 23(2):276-92. PubMed ID: 15637391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of inherited cancer.
    Lindblom A; Nordenskjöld M
    Semin Cancer Biol; 2000 Aug; 10(4):251-4. PubMed ID: 10966848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of adrenocortical carcinomas.
    Soon PS; Sidhu SB
    Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A distinct tumor suppressor gene locus on chromosome 15q21.1 in sporadic form of colorectal cancer.
    Park WS; Park JY; Oh RR; Yoo NJ; Lee SH; Shin MS; Lee HK; Han S; Yoon SK; Kim SY; Choi C; Kim PJ; Oh ST; Lee JY
    Cancer Res; 2000 Jan; 60(1):70-3. PubMed ID: 10646855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer genetics.
    Knudson AG
    Am J Med Genet; 2002 Jul; 111(1):96-102. PubMed ID: 12124744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on cancer-preventive therapeutics.
    Brenner DE
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):25-6, 64. PubMed ID: 16163155
    [No Abstract]   [Full Text] [Related]  

  • 12. APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia.
    Kapitanović S; Cacev T; Radosević S; Spaventi S; Spaventi R; Pavelić K
    Exp Mol Pathol; 2004 Dec; 77(3):193-200. PubMed ID: 15507235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic nature of cancer.
    Boiocchi M
    Eur J Cancer Prev; 1996 Oct; 5(5):370-2. PubMed ID: 8972258
    [No Abstract]   [Full Text] [Related]  

  • 14. [14-3-3sigma (stratifin), a potential tumor suppressor frequently inactivated by methylation in cancer of the breast].
    Jeanteur P
    Bull Cancer; 2000 Jul; 87(7-8):525. PubMed ID: 10969206
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genetic variations of the tumor suppressor TP53: outstanding and strategies of analysis].
    Rangel-López A; Piña-Sánchez P; Salcedo M
    Rev Invest Clin; 2006; 58(3):254-64. PubMed ID: 16958302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of cancer: current knowledge and future possibilities.
    Evans DG
    Hosp Med; 1998 Dec; 59(12):920-3. PubMed ID: 10696352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of risk for human malignancies.
    Garber JE
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):471-83. PubMed ID: 8707768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The molecular diagnosis of cancer].
    Barrera Saldaña H; Martínez Garza S; Ortiz López R
    Rev Invest Clin; 2003; 55(2):128-37. PubMed ID: 12827915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.